valrubicin (AD 32)

36  relevant articles (3 outcomes, 8 trials/studies) found for this Drug

AD 32; AD-32; Celltech brand of valrubicin; N-trifluoroacetyladriamycin 14-valerate; NSC-246131; Paladin brand of valrubicin; Valstar; Valtaxin; (2S-cis)-pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphth acenyl)-2-oxoethyl ester

Relationship Network

Drug Context: Research Results